Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Accounts Payables (2020 - 2022)

Atea Pharmaceuticals (AVIR) has 3 years of Accounts Payables data on record, last reported at $1.1 million in Q3 2022.

  • For Q3 2022, Accounts Payables fell 94.96% year-over-year to $1.1 million; the TTM value through Sep 2022 reached $1.1 million, down 94.96%, while the annual FY2021 figure was $4.5 million, 7456.67% up from the prior year.
  • Accounts Payables reached $1.1 million in Q3 2022 per AVIR's latest filing, down from $13.9 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $22.2 million in Q3 2021 and bottomed at $60000.0 in Q4 2020.
  • Average Accounts Payables over 3 years is $7.2 million, with a median of $4.5 million recorded in 2020.
  • Peak YoY movement for Accounts Payables: surged 7456.67% in 2021, then tumbled 94.96% in 2022.
  • A 3-year view of Accounts Payables shows it stood at $60000.0 in 2020, then soared by 7456.67% to $4.5 million in 2021, then crashed by 75.34% to $1.1 million in 2022.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $1.1 million in Q3 2022, $13.9 million in Q2 2022, and $3.7 million in Q1 2022.